Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 412

1.

Cardiomyocyte functional screening - interrogating comparative electrophysiology of high-throughput model cell systems.

Wells SP, Waddell HM, Sim CB, Lim SY, Bernasochi GB, Pavlovic D, Kirchhof P, Porrello ER, Delbridge LMD, Bell JR.

Am J Physiol Cell Physiol. 2019 Oct 2. doi: 10.1152/ajpcell.00306.2019. [Epub ahead of print]

PMID:
31577512
2.

The National Institute for Health Research (NIHR) Global Health Research Group on Atrial Fibrillation management.

Lip GYH, Guo Y, Lotufo P, Surenthirakumaran R, Humphreys L, Thomas GN; NIHR Global Reach AF Investigators .

Eur Heart J. 2019 Sep 21;40(36):3005-3007. doi: 10.1093/eurheartj/ehz648. No abstract available.

PMID:
31541551
3.

Prognostic models for predicting incident or recurrent atrial fibrillation: protocol for a systematic review.

Dretzke J, Chuchu N, Chua W, Fabritz L, Bayliss S, Kotecha D, Deeks JJ, Kirchhof P, Takwoingi Y.

Syst Rev. 2019 Aug 28;8(1):221. doi: 10.1186/s13643-019-1128-z.

4.

Atrial high-rate episodes: prevalence, stroke risk, implications for management, and clinical gaps in evidence.

Bertaglia E, Blank B, Blomström-Lundqvist C, Brandes A, Cabanelas N, Dan GA, Dichtl W, Goette A, de Groot JR, Lubinski A, Marijon E, Merkely B, Mont L, Piorkowski C, Sarkozy A, Sulke N, Vardas P, Velchev V, Wichterle D, Kirchhof P.

Europace. 2019 Oct 1;21(10):1459-1467. doi: 10.1093/europace/euz172.

PMID:
31377792
5.

Characteristics of patients initiated on edoxaban in Europe: baseline data from edoxaban treatment in routine clinical practice for patients with atrial fibrillation (AF) in Europe (ETNA-AF-Europe).

De Caterina R, Kelly P, Monteiro P, Deharo JC, de Asmundis C, López-de-Sá E, Weiss TW, Waltenberger J, Steffel J, de Groot JR, Levy P, Bakhai A, Zierhut W, Laeis P, Kerschnitzki M, Reimitz PE, Kirchhof P; ETNA-AF-Europe investigators.

BMC Cardiovasc Disord. 2019 Jul 12;19(1):165. doi: 10.1186/s12872-019-1144-x.

6.

Effect of Concomitant Atrial Fibrillation on In-Hospital Outcomes of Non-ST-Elevation-Acute Coronary Syndrome-Related Hospitalizations in the United States.

Mohamed MO, Kirchhof P, Vidovich M, Savage M, Rashid M, Kwok CS, Thomas M, El Omar O, Al Ayoubi F, Fischman DL, Mamas MA.

Am J Cardiol. 2019 Aug 15;124(4):465-475. doi: 10.1016/j.amjcard.2019.05.040. Epub 2019 May 31.

PMID:
31248589
7.

High-Throughput Analysis of Optical Mapping Data Using ElectroMap.

O'Shea C, Holmes AP, Yu TY, Winter J, Wells SP, Parker BA, Fobian D, Johnson DM, Correia J, Kirchhof P, Fabritz L, Rajpoot K, Pavlovic D.

J Vis Exp. 2019 Jun 4;(148). doi: 10.3791/59663.

PMID:
31233017
8.

Education as a vehicle towards quality improvement in the European Society of Cardiology.

Kirchhof P, Beeri R, Fox K, Grapsa J, Kotecha D.

Cardiovasc Res. 2019 Jul 1;115(8):e80-e81. doi: 10.1093/cvr/cvz055. No abstract available.

PMID:
31220211
9.

The Biomarkers NT-proBNP and CA-125 are Elevated in Patients with Idiopathic Atrial Fibrillation.

Dudink EA, Weijs B, Tull S, Luermans JG, Fabritz L, Chua W, Rienstra M, Gelder ICV, Schotten U, Kirchhof P, Crijns HJ.

J Atr Fibrillation. 2018 Dec 31;11(4):2058. doi: 10.4022/jafib.2058. eCollection 2018 Dec.

10.

Development and external validation of predictive models for prevalent and recurrent atrial fibrillation: a protocol for the analysis of the CATCH ME combined dataset.

Chua W, Easter CL, Guasch E, Sitch A, Casadei B, Crijns HJGM, Haase D, Hatem S, Kääb S, Mont L, Schotten U, Sinner MF, Hemming K, Deeks JJ, Kirchhof P, Fabritz L.

BMC Cardiovasc Disord. 2019 May 21;19(1):120. doi: 10.1186/s12872-019-1105-4.

11.

Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined Source.

Diener HC, Sacco RL, Easton JD, Granger CB, Bernstein RA, Uchiyama S, Kreuzer J, Cronin L, Cotton D, Grauer C, Brueckmann M, Chernyatina M, Donnan G, Ferro JM, Grond M, Kallmünzer B, Krupinski J, Lee BC, Lemmens R, Masjuan J, Odinak M, Saver JL, Schellinger PD, Toni D, Toyoda K; RE-SPECT ESUS Steering Committee and Investigators.

N Engl J Med. 2019 May 16;380(20):1906-1917. doi: 10.1056/NEJMoa1813959.

PMID:
31091372
12.

Risk factors for thromboembolic and bleeding events in anticoagulated patients with atrial fibrillation: the prospective, multicentre observational PREvention oF thromboembolic events - European Registry in Atrial Fibrillation (PREFER in AF).

Rohla M, Weiss TW, Pecen L, Patti G, Siller-Matula JM, Schnabel RB, Schilling R, Kotecha D, Lucerna M, Huber K, De Caterina R, Kirchhof P.

BMJ Open. 2019 Mar 30;9(3):e022478. doi: 10.1136/bmjopen-2018-022478.

13.

Cardiac Optogenetics and Optical Mapping - Overcoming Spectral Congestion in All-Optical Cardiac Electrophysiology.

O'Shea C, Holmes AP, Winter J, Correia J, Ou X, Dong R, He S, Kirchhof P, Fabritz L, Rajpoot K, Pavlovic D.

Front Physiol. 2019 Mar 7;10:182. doi: 10.3389/fphys.2019.00182. eCollection 2019. Review.

14.

Clinical characteristics of heart failure patients undergoing atrial fibrillation ablation today in Europe. Data from the atrial fibrillation registries of the European Society of Cardiology and the European Heart Rhythm Association.

Temporelli PL, Tilz RR, Arbelo E, Dagres N, Laroche C, Crijns HJ, Blomstrom-Lundqvist C, Kirchhof P, Lip GYH, Boriani G, Pokushalov E, Nakou E, Brugada J, Tavazzi L.

Eur J Heart Fail. 2019 May;21(5):690-693. doi: 10.1002/ejhf.1458. Epub 2019 Mar 21. No abstract available.

PMID:
30896056
15.

MRI-detected brain lesions in AF patients without further stroke risk factors undergoing ablation - a retrospective analysis of prospective studies.

Herm J, Schurig J, Martinek MR, Höltgen R, Schirdewan A, Kirchhof P, Wieczorek M, Pürerfellner H, Heuschmann PU, Fiebach JB, Haeusler KG.

BMC Cardiovasc Disord. 2019 Mar 12;19(1):58. doi: 10.1186/s12872-019-1035-1.

16.

The Medical Profession, Industry, and Continuing Medical Education: Finding the Balance That's Right for Patients.

Kearney P, Simoons M, Ryden L, Kirchhof P, Pries A, O'Morain C, Bax JJ.

Am J Med. 2019 Aug;132(8):921-925. doi: 10.1016/j.amjmed.2019.02.026. Epub 2019 Mar 8. Review.

PMID:
30853472
17.

SMART About Watches: We Need Technical and Biological Validation of Atrial Fibrillation Screening.

Kalla M, Fabritz L, Kirchhof P.

JACC Clin Electrophysiol. 2019 Feb;5(2):209-211. doi: 10.1016/j.jacep.2018.11.018. No abstract available.

PMID:
30784692
18.

ElectroMap: High-throughput open-source software for analysis and mapping of cardiac electrophysiology.

O'Shea C, Holmes AP, Yu TY, Winter J, Wells SP, Correia J, Boukens BJ, De Groot JR, Chu GS, Li X, Ng GA, Kirchhof P, Fabritz L, Rajpoot K, Pavlovic D.

Sci Rep. 2019 Feb 4;9(1):1389. doi: 10.1038/s41598-018-38263-2.

19.

Digital learning and the future cardiologist.

Rosselló X, Stanbury M, Beeri R, Kirchhof P, Casadei B, Kotecha D.

Eur Heart J. 2019 Feb 7;40(6):499-501. doi: 10.1093/eurheartj/ehy884. No abstract available.

PMID:
30698713
20.

Net Clinical Benefit of Non-Vitamin K Antagonist vs Vitamin K Antagonist Anticoagulants in Elderly Patients with Atrial Fibrillation.

Patti G, Pecen L, Lucerna M, Huber K, Rohla M, Renda G, Siller-Matula J, Ricci F, Kirchhof P, De Caterina R.

Am J Med. 2019 Jun;132(6):749-757.e5. doi: 10.1016/j.amjmed.2018.12.036. Epub 2019 Jan 19.

Supplemental Content

Loading ...
Support Center